We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

119 hedge funds and large institutions have $2.27B invested in Revolution Medicines in 2020 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 12

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

33% more funds holding in top 10

Funds holding in top 10: 9 → 12 (+3)

32% more funds holding

Funds holding: 90 → 119 (+29)

15% more capital invested

Capital invested by funds: $1.98B → $2.27B (+$291M)

0.11% more ownership

Funds ownership: 86.4% → 86.51% (+0.11%)

Holders
119
Holders Change
+29
Holders Change %
+32.22%
% of All Funds
2.11%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.21%
New
42
Increased
37
Reduced
22
Closed
12
Calls
$23K
Puts
–
Net Calls
+$23K
Net Calls Change
+$23K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$38.6M
2
Citadel Advisors
Citadel Advisors
Florida
+$34.2M
3
WP
Woodline Partners
California
+$30.8M
4
State Street
State Street
Massachusetts
+$28.5M
5
BI
BVF Inc
California
+$26.4M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$39.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$21.7M
3
DM
Deerfield Management
New York
-$15.8M
4
Franklin Resources
Franklin Resources
California
-$12.6M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$9.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$10.7M +$8.74M +221,086 +440%
Charles Schwab
27
Charles Schwab
California
$10.6M +$100K +2,532 +1%
Wellington Management Group
28
Wellington Management Group
Massachusetts
$9.19M +$1.12M +28,352 +14%
PA
29
Perceptive Advisors
New York
$8.88M – – –
PHS
30
PFM Health Sciences
California
$8.28M -$5.98M -151,197 -42%
PI
31
Putnam Investments
Massachusetts
$7.93M +$7.92M +200,300 New
Millennium Management
32
Millennium Management
New York
$7.38M +$7.37M +186,429 New
CCM
33
CAAS Capital Management
New York
$6.94M +$6.93M +175,336 New
N
34
Nuveen
North Carolina
$6.05M +$28.2K +713 +0.5%
ROTUOC
35
Regents of the University of California
California
$5.55M +$5.54M +140,155 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$5.44M +$318K +8,049 +6%
OCA
37
Octagon Capital Advisors
New York
$4.99M +$4.99M +126,136 New
JMPWA
38
JP Morgan Private Wealth Advisors
California
$4.32M -$973K -24,597 -18%
First Trust Advisors
39
First Trust Advisors
Illinois
$4.11M +$4.1M +103,718 New
EC
40
Euclidean Capital
New York
$3.7M +$3.69M +93,436 New
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$3.67M +$3.67M +92,820 New
Voloridge Investment Management
42
Voloridge Investment Management
Florida
$3.46M +$3.45M +87,335 New
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$3.29M +$120K +3,042 +4%
Wells Fargo
44
Wells Fargo
California
$3.26M +$1.41M +35,617 +76%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$2.33M +$14K +355 +0.6%
AllianceBernstein
46
AllianceBernstein
Tennessee
$2.23M +$15.8K +400 +0.7%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$2.15M +$1.22M +30,900 +132%
CS
48
Credit Suisse
Switzerland
$2.07M +$1.17M +29,698 +131%
Russell Investments Group
49
Russell Investments Group
United Kingdom
$1.94M +$1.6M +40,437 +478%
Victory Capital Management
50
Victory Capital Management
Texas
$1.92M -$300K -7,578 -14%
1
2
3 4 5

RVMD Hedge Fund Activity: Q4 2020 in Review

119 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q4 2020, worth a combined $2.27B — up 15% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new RVMD positions and 12 closed out — a net gain of 30 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $38.6M. The largest seller was TRV GP III, cutting an estimated $39.5M.

  • 119 institutional investors held Revolution Medicines (RVMD) as of Q4 2020, up from 90 in Q3 2020.
  • Funds reported $2.27B of Revolution Medicines stock for Q4 2020, up 15% quarter-over-quarter.
  • 42 funds opened new Revolution Medicines positions in Q4 2020 and 12 closed out, a net change of +30 holders.
  • The largest Revolution Medicines buyer in Q4 2020 was BlackRock, an estimated $38.6M added.
  • The largest Revolution Medicines seller in Q4 2020 was TRV GP III, an estimated $39.5M sold.

Based on aggregated 13F filings for Q4 2020.